Anti-Mouse CD154 (CD40 Ligand) FITC

Grouped product items
SizePrice Qty
25 ug
100 ug

Additional MR1 Formats

Cat.No.FormatStarting From
16612-30Biotin$ 50.00
16612-60PE$ 65.00
16612-50FITC$ 70.00
Catalog Number : 16612-50


The MR1 monoclonal antibody specifically reacts with mouse CD154, a 39kDA transmembrane glycoprotein also known as CD40 ligand and gp39. CD154 is expressed on activated T cells and plays a role in B-T cell costimulation. The interaction of CD154 with CD40 induces B cell cycle entry and the signaling for T-dependent B cell activation. By interfering with this interaction, the MR1 antibody is reported to inhibit T and B lymphocyte activation.

Additional Information

Armenian Hamster IgG
Research Interest:Adaptive Immunity
Cell Type:Macrophage / Monocyte, T Cells
The product should be stored undiluted at 4°C and should be protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified utilizing affinity chromatography and unreacted dye was removed from the product.
Phosphate-buffered aqueous solution, ≤0.09% Sodium azide, may contain carrier protein/stabilizer, ph7.2.

Noelle, R. J., Roy, M., Shepherd, D. M., Stamenkovic, I., Ledbetter, J. A., & Aruffo, A. (1992). A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proceedings of the National Academy of Sciences89(14), 6550-6554.

Roy, M., Aruffo, A., Ledbetter, J., Linsley, P., Kehry, M., & Noelle, R. (1995). Studies on the interdependence of gp39 and B7 expression and function during antigen‐specific immune responses. European journal of immunology25(2), 596-603.

Van den Eertwegh, A. J., Noelle, R. J., Roy, M. E. E. N. A. K. S. H. I., Shepherd, D. M., Aruffo, A., Ledbetter, J. A., ... & Claassen, E. (1993). In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate TB cell interactions. The Journal of experimental medicine178(5), 1555-1565.

© BioGems International, Inc. All rights reserved.